More recently, several independent laboratories have shown that hepatocyte-specific deletion of Mboat7 (Mboat7HSKO) worsens hepatic steatosis, inflammation, and fibrosis, but unlike the oligonucleotide-based knockdown, does not impact insulin or glucose homeostasis (15, 16, 17). This evidence concerns the gene INS and fatty liver disease.